Do-Hyung Kim

Dr. Do-Hyung Kim

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2023 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
TYTae-Won Yang
Tae-Won Yang
YKYoung-Soo Kim
Young-Soo Kim
DKDo-Hyung Kim
Do-Hyung Kim
JYJung Sook Yeom
Jung Sook Yeom
OKOh-Young Kwon
Oh-Young Kwon

1 January 2020 in Journal of Korean Medical Science
Verified
Journal Article
Open access
DKDo-Hyung Kim
Do-Hyung Kim
OKOh-Young Kwon
Oh-Young Kwon
TYTae-Won Yang
Tae-Won Yang
MKMinhwa Kim
Minhwa Kim
JLJeongrim Lee
Jeongrim Lee
YKYoung-Soo Kim
Young-Soo Kim
Kim DH, et al. J Korean Med Sci. 2020 Feb;35(11):e71. https://doi.org/10.3346/jkms.2020.35.e71

1 October 2020 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
YKYoung-Soo Kim
Young-Soo Kim
DKDo-Hyung Kim
Do-Hyung Kim
TYTae-Won Yang
Tae-Won Yang
MKMinhwa Kim
Minhwa Kim
JLJeongrim Lee
Jeongrim Lee
OKOh-Young Kwon
Oh-Young Kwon
Background and Purpose The increased demand for donor organs has made it crucial to keep the organs of patients with impending brain death (PWIBDs) suitable for transplantation during the process of determining brain death. This study aimed to identify the time taken to determine brain death (TT-BD) in PWIBDs and the associated influencing factors. Methods This study analyzed data collected by the Korean Organ Donation Agency from 15 hospitals in the Yeongnam region of South Korea. There were 414 PWIBDs eligible for inclusion in this study. The data consisted of the TT-BD for PWIBDs and the potential variables influencing the TT-BD. Results The mean age of the 414 PWIBDs was 48.9 years, and 120 of them were female (29.0%). The mean TT-BD was 8.5 days. The presence of spontaneous movements (SMs) and craniotomy significantly affected the TT-BD. The mean TT-BDs were 13.9 and 8.2 days in the PWIBDs with and without SMs, respectively, and 9.8 and 8.0 days in the PWIBDs with and without craniotomy, respectively. Conclusions The SMs in PWIBDs and a craniotomy performed immediately before starting the process of determining brain death seem to be related to lengthening the TT-BD.

1 January 2013 in Fish & Shellfish Immunology
Verified
Journal Article
Closed access
SHSeong Don Hwang
Seong Don Hwang
JKJuwon Kim
Juwon Kim
MKMu-Chan Kim
Mu-Chan Kim
DKDo-Hyung Kim
Do-Hyung Kim
CPChan-Il Park
Chan-Il Park

5 May 2026 in Journal of the American Heart Association
Verified
Journal Article
Open access
WYWookjin Yang
Wookjin Yang
Tae-Jin SongTae-Jin Song
Tae-Jin Song
Seong-Ho KohSeong-Ho Koh
Seong-Ho Koh
HJHye Seon Jeong
Hye Seon Jeong
SSSung-Il Sohn
Sung-Il Sohn
SLSeung-Hoon Lee
Seung-Hoon Lee
Background: Current stroke guidelines lack subtype‐specific recommendations for optimal low‐density lipoprotein cholesterol targets. Indeed, most lipid‐lowering trials have not differentiated between stroke subtypes or focused primarily on large artery atherosclerosis, leaving a gap in evidence for other stroke subtypes, such as small vessel occlusion stroke. This study is designed to evaluate whether intensive lipid‐lowering therapy is superior to standard therapy in reducing major adverse cardiovascular events among patients with small vessel occlusion stroke. Methods: SVO70 (Optimal Target Low‐Density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke) is a multicenter, prospective, randomized, open, blinded‐end point clinical trial in which adult patients with neuroimaging‐confirmed small vessel occlusion stroke within 180 days of randomization will be enrolled. Key exclusion criteria include predefined low‐density lipoprotein cholesterol targets for other comorbidities, contraindications to statin, and pregnancy or lactation. Eligible participants will be randomized 1:1 to achieve low‐density lipoprotein cholesterol <70 mg/dL (intensive group) or 90 to 110 mg/dL (standard group). The trial aims to enroll 4016 participants over a 2‐year recruitment period, with a minimum follow‐up of 4 years. The primary end point is the occurrence of major adverse cardiovascular events, defined as cardiovascular death, stroke, and acute coronary syndrome, during the follow‐up period. Secondary end points include (1) any stroke, (2) ischemic stroke or transient ischemic attack, (3) hemorrhagic stroke, (4) cardiovascular death, (5) myocardial infarction, (6) all‐cause death, and (7) acute coronary syndrome. Conclusions: This study will provide valuable information for determining optimal low‐density lipoprotein cholesterol targets for patients with small vessel occlusion stroke. Registration: URL: https://ClinicalTrials.gov ; Unique Identifier: NCT06649240, Clinical Research Information Service (KCT0009043).

30 October 2021 in Annals of Clinical Neurophysiology
Verified
Journal Article
Open access
PDF file
DKDo-Hyung Kim
Do-Hyung Kim
HYHong Gi Yeom
Hong Gi Yeom
MKMinjung Kim
Minjung Kim
SKSeung Hwan Kim
Seung Hwan Kim
TYTae-Won Yang
Tae-Won Yang
YKYoung-Soo Kim
Young-Soo Kim
A brain-computer interface (BCI) is a technology that acquires and analyzes electrical signals from the brain to control external devices. BCI technologies can generally be used to control a computer cursor, limb orthosis, or word processing. This technology can also be used as a neurological rehabilitation tool for people with poor motor control. We reviewed historical attempts and methods toward predicting arm movements using brain waves. In addition, representative studies of minimally invasive and noninvasive BCI were summarized.